{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-125598","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2023-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.419212+00:00","generated_at":"2026-06-07T13:20:35.499596+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CytoSorbents closes $10.3M registered direct offering with insider participation","bullets":["Closed offering of 7,733,090 shares and warrants for 2,706,561 shares at $1.33/unit, gross $10.3M.","Net proceeds ~$9.83M; warrants exercisable at $2.00/share, expire in 5 years.","Insiders (C-suite, board, key leaders) invested $435,000 in the offering.","Proceeds to fund DrugSorb-ATR regulatory efforts, CytoSorb growth, clinical studies, and R&D.","CEO expects initial STAR-T trial data before end of December 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-125598","json":"https://secwatch.observer/filing/0001104659-23-125598.json","markdown":"https://secwatch.observer/filing/0001104659-23-125598.md","text":"https://secwatch.observer/filing/0001104659-23-125598.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923125598/0001104659-23-125598-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923125598/tm2332718d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T13:20:35.499596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}